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Antioxidant Status in Hypercholesteremic Rats
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Department of Biosciences, Sardar Patel University, Vallabh Vidyanagar 388 120, Gujarat, India
Hyperlipidemia/hypercholesteremia are major risk factors for atherosclerosis and cardiovascular
diseases. Root of Asparagus racemosus (AR) is widely used in Ayurvedic system of medicine in
India and is known for its steroidal saponin content. This study was designed to investigate the
hypocholesteremic and antioxidant potential of AR root in both normo- and hypercholes-
teremic animals. Normal and hypercholesteremic male albino rats were administered with root
powder of AR (5 and 10g% dose levels) along with normal and hypercholesteremic diets,
respectively, for a duration of 4 weeks. Plasma and hepatic lipid profiles, fecal sterol, bile acid
excretion and hepatic antioxidant activity were assessed. Inclusion of AR root powder in diet,
resulted in a dose-dependant reduction in plasma and hepatic lipid profiles, increased fecal
excretion of cholesterol, neutral sterol and bile acid along with increases in hepatic HMG-CoA
reductase activity and bile acid content in hypercholesteremic rats. Further, AR root also
improved the hepatic antioxidant status (catalase, SOD and ascorbic acid levels). No significant
changes in lipid and antioxidant profiles occurred in the normocholesteremic rats administered
with AR root powder. AR root appeared to be useful as a dietary supplement that offers a
protection against hyperlipidemia/hypercholesteremia in hypercholesteremic animals. The
results of the present study indicate that the potent therapeutic phyto-components present in
AR root i.e. phytosterols, saponins, polyphenols, flavonoids and ascorbic acid, could be
responsible for increased bile acid production, elimination of excess cholesterol and elevation of
hepatic antioxidant status in hypercholesteremic conditions.
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Introduction
Atherosclerotic cardiovascular disease is rapidly becom-
ing a major cause of death in many societies throughout
the world due to changed dietary habits and occupational
stress. The hallmark of atherosclerosis is the accumula-
tion of cells containing excessive lipids (i.e. foam cells)
within the arterial wall. The major risk factors for the
development of atherosclerosis are hypercholesteremia
and elevated low-density lipoprotein cholesterol (LDL-C)
concentration (1). Persistent hypercholesteremia results
from prolonged circulation of lipid-rich lipoproteins
that increase oxidative stress leading to oxidative
modification of LDL to oxy-LDL (2,3). A number of
plants with potent therapeutic components such as fibers,
sterols, saponins, polyphenols, flavonoids, etc., have been
investigated for their antihyperlipidemic, antioxidant
and antiatherosclerotic properties. These compounds
are reported to be beneficial with great variation in
magnitude and mechanism of action and hence have a
potential therapeutic value in combating multifactorial
atherosclerotic disorders (4–9). Research in such plant-
based diet therapy therefore, has a major role in
reducing the risk of atherosclerosis, which can lead
to development of effective and better management
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cular diseases.
Asparagus racemosus (AR) willd. (Family: Liliaceae),
commonly known as shatavari, satawar or satmuli, is
found at low altitudes throughout India. The dried root
of the plant is used in Ayurveda as a tonic, galactogogue,
aphrodisiac, rejuvenator, antispasmodic, antiulcerous and
antiinflammatory and the medicinal/pharmacological
value of AR root is attributed to the presence of steroidal
saponins and sapogenins (10,11). The root of AR is also
used in the treatment of nervous disorders, dyspepsia,
diarrhea, dysentery, tumors, hyperdipsia, neuropathy and
hepatopathy (11). This plant is reported to have
immunostimulant, antihepatotoxic and antioxytocic
activities (11,12). Recent reports on AR indicate that
the root extracts have antioxidant and antidiarrheal
activities in laboratory animals (13,14). The present
study was undertaken to investigate the potential of
Asparagus root (powder) as a dietary supplement in
normalizing the hyperlipidemic/hypercholesteremic and
oxidative stress conditions induced by chronic intake of
lipid-rich diets with regard to plasma and hepatic lipid
profiles, cholesterol metabolism and antioxidant status.
Additionally, the effect of Asparagus root was assessed
on normocholesteremic animals with a view to investigate
and to compare its influence on lipid metabolism in both
normal and hyperlipidemic rats.
Methods
Plant Material
Roots of AR were collected from university botanical
garden, Sardar Patel University, Vallabh Vidyanagar,
Gujrat, India. The roots were washed thoroughly with
tap water and dried at 37 C in an incubator, diced into
small pieces, powdered in a mixer grinder and used for
the experiments. Phytosterol and saponin content of the
root were estimated using ferric chloride—sulphuric acid
and vanillin-sulphuric acid methods, respectively (15,16).
The polyphenol and flavonoid content of the root were
analyzed using Folin–Ciocalteu and vanillin-sulphuric
acid reagents, respectively (17,18). The total ascorbic
acid (TAA) content was estimated using 2,4-dinitrophe-
nyl hydrazine reagent (19) (Table 1).
Albino Rats
Male albino rats (Charles Foster) weighing 150–200g
were used for the experiment. Rats were housed
individually with ad libitum access to water in a well-
ventilated animal unit (26 2 C, humidity 62%, 12h
light/dark cycle). Rats were fed standard chow (Pranav
Agro-Industries Ltd., Baroda, India). The care and
procedures adopted for the present investigation were in
accordance with the approval of Institutional Animal
Ethics Committee.
Experimental Design
After a 10-day adaptation period, 48 rats were divided
into 6 groups of 8 rats each (NC-normal control; NAR-I-
normal animals administered with 5g% AR root powder;
NAR-II- normal animals administered with 10g% AR
root powder; HC- hypercholesteremic animals; HAR-I-
hypercholesteremic animals administered with 5g% AR
root powder; HAR-II- hypercholesteremic animals
administered with 10g% AR root powder). Hypercho-
lesteremia was induced by addition of 0.5g% cholesterol
and 1.0g% sodium taurocholate to the basal diet.
The basal diet contained carbohydrates (56g%), proteins
(22g%), fat (4g%), fiber (4g%) and mineral mixture
(6g%).
Their body weight and food intake were recorded every
third day during the experimental period (4 weeks). Fecal
samples of the last 24h of the experimental period were
collected from individual animals from each group (5g/
rat), dried, powdered and extracted for fecal sterols. At
end of experiment, animals were deprived of food
overnight, sacrificed under light anesthesia and blood
was collected immediately by cardiac puncture; plasma
was separated by centrifugation. Liver was excised and,
both plasma and liver were kept frozen until analyzed.
Biochemical Analysis
Plasma and Hepatic Lipid Profiles
Plasma total lipid (TL) content was estimated by
sulphophosphovanillin method (20). Total cholesterol
(TC) and triglycerides (TG) were estimated by ferric
perchlorate-sulphuric acid and L-a-glycerophosphate
oxidase (GPO) methods, respectively (21,22). HDL-
cholesterol (HDL-C) was extracted using phosphotung-
state-magnesium chloride reagent from plasma (23) and
estimated (21). LDL-C, very low-density lipoprotein
cholesterol (VLDL-C) and Atherogenic Index (AI)
was calculated (24). The liver TL was extracted in
chloroform: methanol (2:1) (25) and estimated by
Table 1. Phytoanalysis of AR root (Triplicate values: mean standard
deviation)
Phytoconstituents mg/g dry tissue AR root
Phytosterols 7.90 0.90 (0.79%)
Saponins 88.33 1.61 (8.833%)
Polyphenols 16.92 1.10 (1.692%)
Flavonoids 4.76 0.32 (0.476%)
Total ascorbic acid 7.62 0.06 (0.762%)
220 Asparagus root as hypolipidemic agentgravimetric analysis. TC and TG were extracted (25) and
estimated (21,22).
Hepatic HMG-CoA Reductase and Bile Acid Profile
Hepatic HMG-CoA reductase (EC 1.1.1.34) activity was
measured in terms of the ratio of HMG-CoA to
mevalonate (26). Colorimetric assays were carried out
for both HMG-CoA and mevalonate using hydroxyla-
mine reagent at alkaline and acidic PH, and the ratio of
HMG-CoA to mevalonate determined. It is inversely
proportional to the enzyme activity i.e. the increase in
ratio corresponds to a decrease in enzyme activity. The
alkaline-ethanolic extract of hepatic bile acid was
acidified and estimated using vanillin-phosphoric acid
reagent (27).
Fecal Cholesterol, Neutral Sterol and Bile Acid Content
The fecal cholesterol, neutral sterols and bile acid were
extracted using alkaline methanol medium (28) for fecal
cholesterol and neutral sterols estimation (21,29). A
portion of the extract was acidified and used for bile
acid estimation (27).
Hepatic Antioxidant Profile
Catalase (EC 1.11.1.6) was assayed spectrophotometri-
cally as decomposition of H2O2 at 240nm (30) and
superoxide dismutase (SOD; EC 1.15.1.1) activity was
measured using nitrobluetetrazolium reduction method
(31). TAA contents were estimated (19).
Statistical Evaluation
Results are expressed as means SEM. Significant
differences among the groups were determined by one-
way ANOVA using 10th version of SPSS with Duncan’s
test as post hoc analysis. Differences were considered
significant if P<0.05.
Results
Body Weight, Food Intake and Liver Weight
There were no significant differences in final body
weights; food intake or liver weights in all AR-treated
groups except HAR-II group. This group registered a
significant decline in liver weight (P<0.05, 22%) as
compared to HC group (data not presented).
Plasma and Hepatic Lipids
When normal animals administered with AR root
powder at 5 and 10g% dosages, the plasma and hepatic
lipid profiles showed no significant differences although
NAR-II animals registered a significant increase in
plasma HDL-C fraction (P<0.05, 11%) as compared
to NC animals. However, AR administered hypercholes-
teremic groups (HAR-I and HAR-II) revealed significant
decreases (P<0.05) in TL (14%, 21%), TC (25%, 35%),
LDL-C (32%, 45%) and AI (37%, 49%) with increase in
HDL-C (P<0.05, 19%, 27%) as compared to HC
group. The TG and VLDL-C content however, remained
unaffected in these groups (Figs. 1–7). The HAR-I and
HAR-II groups also registered a significant reduction
(P<0.05) in hepatic TL (13%, 24%) and TC
(21%, 36%) while the TG level showed no significant
change (Figs. 8–10).
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Figure 1. Effect of AR (root powder) feeding on plasma TL levels.
Results are mean SEM, n=8. Values with different letters are
significantly different from each other (P<0.05).
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Figure 2. Effect of AR feeding on plasma total cholesterol levels.
Results are mean SEM, n=8. Values with different letters are
significantly different from each other (P<0.05).
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Figure 3. Effect of AR feeding on plasma TG levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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The NAR-I and NAR-II groups revealed no significant
changes in hepatic HMG-CoA reductase activity and bile
acid production when compared to those of NC animals.
The HAR-I and HAR-II groups however, exhibited a
significant rise (P<0.05) in HMG-CoA reductase
activity (25%, 35%) and bile acid production (28%,
36%) as compared to HC group (Figs. 11 and 12). There
was no significant variation in fecal cholesterol, neutral
sterol and bile acid content of NAR-I and NAR-II
groups as compared to NC group. However, both HAR-I
and HAR-II groups revealed significantly higher
(P<0.05) amounts of cholesterol (29%, 56%), neutral
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Figure 4. Effect of AR feeding on plasma HDL-C levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 5. Effect of AR feeding on plasma LDL-C levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 6. Effect of AR feeding on plasma VLDL-C levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 7. Effect of AR feeding on plasma AI. Results are mean SEM,
n=8. Values with different letters are significantly different from each
other (P<0.05).
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Figure 8. Effect of AR feeding on liver TL levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 9. Effect of AR feeding on liver total cholesterol levels. Results
are mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 10. Effect of AR feeding on liver TG levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
222 Asparagus root as hypolipidemic agentsterol (30%, 55%) and bile acid (28%, 37%) in fecal
matter when compared to HC group (Figs. 13–15).
Antioxidant Status
The antioxidant status (activities of catalase, SOD and
ascorbic acid content) did not vary significantly in NAR-
I and NAR-II groups from that of NC. However, HAR-I
and HAR-II groups registered a significant increase
(P<0.05) in catalase (33%, 35%) and SOD (21%,
29%) activities and TAA content (20%, 23%) as
compared to HC group (Figs. 16–18).
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Figure 11. Effect of AR feeding on liver HMG-CoA reductase activity.
Results are mean SEM, n=8. Values with different letters are
significantly different from each other (P<0.05).
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Figure 12. Effect of AR feeding on liver bile acid levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 13. Effect of AR feeding on fecal cholesterol levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 14. Effect of AR feeding on fecal neutral sterol levels. Results
are mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 15. Effect of AR feeding on fecal bile acid levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 16. Effect of AR feeding on liver catalase activity. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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Figure 17. Effect of AR feeding on liver SOD activity. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
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The lipid-lowering effects of AR root in hypercholestere-
mic rats demonstrated in the present investigation are
related primarily to an increased excretion of cholesterol,
neutral sterols, bile acid and an increase in hepatic bile
acid content. In this context, the phytosterol (0.79g%)
and saponin (8.83g%) contents of AR root (besides
polyphenols, 1.69g%; flavonoids, 0.47g%; ascorbic acid,
0.76g%) could be responsible for increased fecal sterol
excretion and decreased cholesterol levels in the hyperch-
olesteremic rats, as on one hand phytosterols are reported
to compete and displace cholesterol from the intestinal
bile acid micelles and decrease the cholesterol circulation
(7,32) and on the other hand, saponins precipitate
cholesterol from micelles and interfere with enterohepatic
circulation of bile acids making it unavailable for
intestinal absorption of cholesterol leading to a reduction
in plasma cholesterol levels (8,33).
Although the main component of the Asparagus root is
a steroidal saponin, the root also contains alkaloids,
flavonoids, sterols, terpenes, tannins, phenolics and
mucilage (34). The ethanol extract of the root was
shown to contain several steroidal saponins—Shatavarins
(sarsasapogenins) of which Shatavarin-I is the major
glycosidal component, which was characterized as (25S,
22R)-3-O-b-D-glucopyranosyal- (1!4)-[a-L-rhamnopyra-
nosyal- (1!2)]-b-D-glucopyrano-side-26-O-b-D-glucopyra-
noside-5b-furostane-3b, 22,26-triol (35). Shatavarin-IV of
the root was identified as b-D-glucose- (1!4)-b-D-
glucose- (1!)-a-L-rhamnose- (1!2) sarsasapogenin (12).
However, no reports are available on biological effects of
Shatavarins (sarsasapogenins) with reference to lipid
metabolism. Earlier reports on saponins such as steroid
glycosides digitonin (36), tomatine (37), sarsasaponin
(38), steroid saponins and sapogenins of fenugreek
fractions (39) as well as triterpenoid glycosides of alfalfa
(40), soya, quillaja and saponaria (38) indicated that
they inhibit intestinal cholesterol absorption and
reduce plasma cholesterol concentrations in diet-induced
hypercholesteremic animal models.
Whereas steroid glycosides such as digi-
tonin and tomatine bind to cholesterol to induce its
precipitation in vitro (36,37) and inhibit cholesterol
absorption without affecting bile acid absorption in vivo
(37), many of the triterpenoid saponins interfere with
micelle size and structure (41) and alter bile acid
absorption in addition to inhibiting cholesterol absorp-
tion (36,41). Besides, saponins also lower the plasma
LDL-C levels through an increased turnover of LDL-C
to hepatic tissue, which is then converted to bile acid (8).
Although saponins are reported to lower TG by
inhibiting pancreatic lipase activity (42) and the subse-
quent decline in VLDL-C levels could be directly
correlated to a decline in TG levels (43), the present
study does not demonstrate any significant changes in
both TG and VLDL-C levels in any groups, the
mechanism for which is unclear.
An increased HMG-CoA reductase activity in both
HAR-I and HAR-II groups compared to that of HC
group appears to constitute a metabolic alteration
occurring in hepatic tissue as a response to dietary
saponin; such a compensatory increase in hepatic
cholesterol synthesis occurs when intestinal cholesterol
absorption is impaired or when bile acid synthesis is
stimulated (8). However, the normocholesteremic animals
(NC) under AR treatment, exhibited no significant
variations either in excretion of cholesterol, neutral
sterols and bile acid or in hepatic cholesterol and bile
acid content. This observation indicates that the effect of
AR root on body cholesterol metabolism is strongly
influenced by hyperlipidemia and hypercholesteremia. It
is well documented that while a low level of HDL-C is
indicative of high risk for cardiovascular disease, an
increase in HDL-C level could potentially contribute to
antiatherogenicity, inhibit LDL oxidation and protect
endothelial cells from the cytotoxic effects of oxidized
LDL (44,45). In the present context, a significant increase
in plasma HDL-C levels with a concurrent decline in
plasma cholesterol level and an improvement in AI of
HAR-I and HAR-II animals clearly indicate the bene-
ficial role of AR root administration to hypercholestere-
mic animals.
An increased production of superoxide anions and
metabolites and/or a reduced bioavailability of antiox-
idants causes oxidative damage to cells and tissues.
An imbalance between pro-oxidant and antioxidant levels
in the body gives rise to cellular oxidative stress that plays
an important role in the genesis of cardiovascular diseases
(46). Cholesterol- rich diets are known to increase both
LDL-C levels and oxidative stress and result in increased
oxidized LDL levels leading to atherosclerotic plaque
formation (3). Several studies suggest that naturally
occurring antioxidants such as polyphenols, flavonoids
and vitamin C in diet may a play role as antiatherogenic
agents (3,9,47,48). The polyphenols and flavonoids are
known to scavenge-free radicals, including hydroxyl and
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Figure 18. Effect of AR feeding on liver TAA levels. Results are
mean SEM, n=8. Values with different letters are significantly
different from each other (P<0.05).
224 Asparagus root as hypolipidemic agentsuperoxide anions, inhibit lipid peroxidation and improve
lipid profiles (47–50). Both these are also known to
stimulate catalase and SOD gene transcription and
decrease malondialdehyde concentration (51,52). Several
lines of evidence suggest that ascorbic acid is a powerful
antioxidant in biological systems as an electron donor,
readily scavenging the reactive oxygen and nitrogen species
to prevent cellular oxidative damage (53) and to reduce
genotoxic effects of lipid peroxidation products (54).
Further, ascorbic acid can also stimulate SOD activity
(55). Wiboonpun et al. (56) identified that roots of AR
possess an in vitro antioxidant property against DPPH and
the antioxidant compound was identified as racemofuran
along with two known compounds—asparagamine A and
racemosol. Furan fatty acids possess a radical-scavenging
ability and are generated in large quantities in both plants
and algae, and when animals consume foods containing
these furan fatty acids, they contribute to the body’s overall
antioxidant activity owing to their affinity to react with
peroxyl radicals (57). Additionally, Asparagus root extract
possesses in vivo antioxidant activity in rats although the
principles responsible for this antioxidant activity were not
reported (13). Presently noted higher levels of hepatic
catalase and SOD activities in HAR-I and HAR-II groups
indicate the possible role of polyphenols and flavonoids of
AR root, in modulating the expression of both catalase and
SOD activities. While the hypercholesteremia reduced the
hepatic ascorbic acid content in HC group, both HAR-I
and HAR-II groups registered significantly higher amounts
of ascorbic acid in hepatic tissues. Taken together, these
observations indicate that AR root powder administration
to HC animals can reduce lipid levels in both blood and
liver, increase bile acid production and modulate antiox-
idant enzyme activities. We conclude that AR root
administration could ameliorate hyperlipidemic/hypercho-
lesteremic and oxidative stress in hypercholesteremic
conditions.
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